Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 54, Issue , 2014, Pages 76-82

  Petit, Anne Cécile ^a   Quesseveur, Gaël ^b   Gressier, Florence ^a   Colle, Romain ^a   David, Denis J ^b   Gardier, Alain M ^b   Ferreri, Florian ^c   Lépine, Jean Pierre ^d   Falissard, Bruno ^a   Verstuyft, Céline ^e,f   Guiard, Bruno P ^b   Corruble, Emmanuelle ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b University of Paris XI   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f EA4123   (France)

Author keywords

5 HT2A receptor; Animal model; Major depression; Single nucleotide polymorphism; Translational study

Indexed keywords

SEROTONIN 2A RECEPTOR; CORTICOSTERONE;

ADULT; AGED; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; PHENOTYPE; SEROTONIN 2A RECEPTOR GENE; SEROTONINERGIC TRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; WILD TYPE; 129 MOUSE; ADOLESCENT; ANIMAL; ANXIETY DISORDER; CAUCASIAN; CLINICAL TRIAL; DISEASE MODEL; EXPLORATORY BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; MAZE TEST; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANXIETY DISORDERS; CORTICOSTERONE; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXPLORATORY BEHAVIOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MAZE LEARNING; MICE, 129 STRAIN; MICE, KNOCKOUT; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT2A; YOUNG ADULT;

EID: 84902440591     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.04.013     Document Type: Article

References (78)

1. Akin D., Manier D.H., Sanders-Bush E., Shelton R.C. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology 2004, 29(11):2081-2087.
2. Anguelova M., Benkelfat C., Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol psychiatry 2003, 8(6):574-591.
3. Arias B., Gasto C., Catalan R., Gutierrez B., Pintor L., Fananas L. The 5-HT(2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am J Med Genet 2001, 105(8):801-804.
4. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994, 35(7):457-463.
5. Baldwin D., Rudge S. The role of serotonin in depression and anxiety. Int Clin Psychopharmacol 1995, 9(Suppl. 4):41-45.
6. Boothman L.J., Sharp T. A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control. Neuroreport 2005, 16(9):891-896.
7. Boothman L.J., Allers K.A., Rasmussen K., Sharp T. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br J Pharmacol 2003, 139(5):998-1004.
8. Bortolozzi A., Amargos-Bosch M., Adell A., Diaz-Mataix L., Serrats J., Pons S., et al. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. Eur J Neurosci 2003, 18(5):1235-1246.
9. Bray N.J., Buckland P.R., Hall H., Owen M.J., O'Donovan M.C. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol Psychiatry 2004, 9(1):109-114.
10. Choi M.J., Lee H.J., Lee H.J., Ham B.J., Cha J.H., Ryu S.H., et al. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene. Neuropsychobiology 2004, 49(1):38-41.
11. Christiansen L., Tan Q., Iachina M., Bathum L., Kruse T.A., McGue M., et al. Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biol Psychiatry 2007, 61(2):223-230.
12. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62(4):479-493.
13. Diaz S.L., Maroteaux L. Implication of 5-HT(2B) receptors in the serotonin syndrome. Neuropharmacology 2011, 61(3):495-502.
14. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 2000, 96(1):56-60.
15. Dwivedi Y., Mondal A.C., Payappagoudar G.V., Rizavi H.S. Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology 2005, 48(2):204-214.
16. Enoch M.A., Goldman D., Barnett R., Sher L., Mazzanti C.M., Rosenthal N.E. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Mol Psychiatry 1999, 4(1):89-92.
17. Falkenberg V.R., Gurbaxani B.M., Unger E.R., Rajeevan M.S. Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association. Neuromolecular Med 2011, 13(1):66-76.
18. Farley S., Apazoglou K., Witkin J.M., Giros B., Tzavara E.T. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 2010, 13(9):1207-1218.
19. Fernandes C., McKittrick C.R., File S.E., McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 1997, 22(7):477-491.
20. Garratt J.C., Kidd E.J., Wright I.K., Marsden C.A. Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI. Eur J Pharmacol 1991, 199(3):349-355.
21. Giegling I., Hartmann A.M., Moller H.J., Rujescu D. Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 2006, 96(1-2):75-81.
22. Gourley S.L., Taylor J.R. Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr Protoc Neurosci 2009, (October, CHAPTER: Unit-9.32).
23. Guilloux J.P., Seney M., Edgar N., Sibille E. Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods 2011, 197(1):21-31.
24. Guy W. The Clinical Global Impression Scale. ECDEU Assessment Manual for Psychopharmacology-Revised 1976, 218-222. US Dept. of Health, Education and Welfare, ADAMHA, MIMH Psychopharmacology Research Branch, Rockville, MD.
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
26. Hazelwood L.A., Sanders-Bush E. His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation. Mol Pharmacol 2004, 66(5):1293-1300.
27. Hemrick-Luecke S.K., Evans D.C. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis. Neuropharmacology 2002, 42(2):162-169.
28. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993, 614(1-2):37-44.
29. Hrdina P.D., Bakish D., Chudzik J., Ravindran A., Lapierre Y.D. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci 1995, 20(1):11-19.
30. Hrdina P.D., Bakish D., Ravindran A., Chudzik J., Cavazzoni P., Lapierre Y.D. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res 1997, 66(2-3):73-85.
31. Illi A., Setala-Soikkeli E., Viikki M., Poutanen O., Huhtala H., Mononen N., et al. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 2009, 20(12):1125-1128.
32. Jansson M., Gatz M., Berg S., Johansson B., Malmberg B., McClearn G.E., et al. Association between depressed mood in the elderly and a 5-HTR2A gene variant. Am J Med Genet B Neuropsychiatr Genet 2003, 120B(1):79-84.
33. Kamata M., Suzuki A., Yoshida K., Takahashi H., Higuchi H., Otani K. Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder. J Affect Disord 2011, 135(1-3):374-376.
34. Kishi T., Kitajima T., Tsunoka T., Ikeda M., Yamanouchi Y., Kinoshita Y., et al. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population. Neurosci Res 2009, 64(2):231-234.
35. Lee H.J., Sung S.M., Lim S.W., Paik J.W., Leen K. Seasonality associated with the serotonin 2A receptor -1438 A/G polymorphism. J Affect Disord 2006, 95(1-3):145-148.
36. Lee T.T., Redila V.A., Hill M.N., Gorzalka B.B. 5-HT(2A) receptor mediated neuronal activation within the paraventricular nucleus of the hypothalamus is desensitized following prolonged glucocorticoid treatment. Eur J Pharmacol 2009, 602(1):54-57.
37. Li D., Duan Y., He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006, 340(3):1006-1015.
38. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8(6-7):523-532.
39. Martin-Ruiz R., Puig M.V., Celada P., Shapiro D.A., Roth B.L., Mengod G., et al. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 2001, 21(24):9856-9866.
40. Minov C., Baghai T.C., Schule C., Zwanzger P., Schwarz M.J., Zill P., et al. Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 2001, 303(2):119-122.
41. Myers R.L., Airey D.C., Manier D.H., Shelton R.C., Sanders-Bush E. Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry 2007, 61(2):167-173.
42. Ohara K., Nagai M., Tsukamoto T., Tani K., Suzuki Y., Ohara K. 5-HT2A receptor gene promoter polymorphism -1438G/A and mood disorders. Neuroreport 1998, 9(6):1139-1141.
43. Ozaki N., Manji H., Lubierman V., Lu S.J., Lappalainen J., Rosenthal N.E., et al. A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization. J Neurochem 1997, 68(5):2186-2193.
44. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002, 159(3):419-429.
45. Pandey D.K., Mahesh R., Kumar A.A., Rao V.S., Arjun M., Rajkumar R. A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol Biochem Behav 2010, 94(3):363-373.
46. Parsons M.J., D'Souza U.M., Arranz M.J., Kerwin R.W., Makoff A.J. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004, 56(6):406-410.
47. Patel J.G., Bartoszyk G.D., Edwards E., Ashby C.R. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 2004, 52(1):73-75.
48. Polesskaya O.O., Sokolov B.P. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002, 67(6):812-822.
49. Polesskaya O.O., Aston C., Sokolov B.P. Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. J Neurosci Res 2006, 83(3):362-373.
50. Quesseveur G., Nguyen H.T., Gardier A.M., Guiard B.P. 5-HT2 ligands in the treatment of anxiety and depression. Expert Opin Investig Drugs 2012, 21(11):1701-1725.
51. Quesseveur G., Reperant C., David D.J., Gardier A.M., Sanchez C., Guiard B.P. 5-HT(2A) receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. Exp Brain Res 2013, 226(2):285-295.
52. Rainer Q., Xia L., Guilloux J.P., Gabriel C., Mocaer E., Hen R., et al. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int J Neuropsychopharmacol 2011, 1-15.
53. Rittenhouse P.A., Bakkum E.A., Levy A.D., Li Q., Carnes M., van de Kar L.D. Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors. J Pharmacol Exp Ther 1994, 271(3):1647-1655.
54. Saiz P.A., Garcia-Portilla M.P., Paredes B., Arango C., Morales B., Alvarez V., et al. Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts. Psychiatr Genet 2008, 18(5):213-218.
55. Saphier D., Farrar G.E., Welch J.E. Differential inhibition of stress-induced adrenocortical responses by 5-HT1A agonists and by 5-HT2 and 5-HT3 antagonists. Psychoneuroendocrinology 1995, 20(3):239-257.
56. Schiller L., Jahkel M., Kretzschmar M., Brust P., Oehler J. Autoradiographic analyses of 5-HT1A and 5-HT2A receptors after social isolation in mice. Brain Res 2003, 980(2):169-178.
57. Serretti A., Drago A., De Ronchi D. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr Med Chem 2007, 14(19):2053-2069.
58. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. [quiz 4-57].
59. Sheline Y.I., Bardgett M.E., Jackson J.L., Newcomer J.W., Csernansky J.G. Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 1995, 37(7):442-447.
60. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158(4):1406-1415.
61. Sibille E., Sarnyai Z., Benjamin D., Gal J., Baker H., Toth M. Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice. Mol Pharmacol 1997, 52(6):1056-1063.
62. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A., et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 1998, 3(1):42-49.
63. Sterner E.Y., Kalynchuk L.E. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(5):777-790.
64. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85(3):367-370.
65. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008, 64(4):293-301.
66. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34(6):1363-1380.
67. Tencomnao T., Thongrakard V., Phuchana W., Sritharathikhun T., Suttirat S. No relationship found between -1438A/G polymorphism of the serotonin 2A receptor gene (rs6311) and major depression susceptibility in a northeastern Thai population. Genet Mol Res 2010, 9(2):1171-1176.
68. Tsai S.J., Hong C.J., Hsu C.C., Cheng C.Y., Liao W.Y., Song H.L., et al. Serotonin-2A receptor polymorphism (102T/C) in mood disorders. Psychiatry Res 1999, 87(2-3):233-237.
69. Van de Kar L.D., Javed A., Zhang Y., Serres F., Raap D.K., Gray T.S. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 2001, 21(10):3572-3579.
70. Vaquero-Lorenzo C., Baca-Garcia E., Diaz-Hernandez M., Perez-Rodriguez M.M., Fernandez-Navarro P., Giner L., et al. Association study of two polymorphisms of the serotonin-2A receptor gene and suicide attempts. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(5):645-649.
71. Wang S., Zhang K., Xu Y., Sun N., Shen Y., Xu Q. An association study of the serotonin transporter and receptor genes with the suicidal ideation of major depression in a Chinese Han population. Psychiatry Res 2009, 170(2-3):204-207.
72. Weisstaub N.V., Zhou M., Lira A., Lambe E., Gonzalez-Maeso J., Hornung J.P., et al. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313(5786):536-540.
73. Wittke-Thompson J.K., Pluzhnikov A., Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76(6):967-986.
74. Wright I.K., Garratt J.C., Marsden C.A. Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex. Br J Pharmacol 1990, 99(2):221-222.
75. Yates M., Leake A., Candy J.M., Fairbairn A.F., McKeith I.G., Ferrier I.N. 5HT2 receptor changes in major depression. Biol Psychiatry 1990, 27(5):489-496.
76. Zaniewska M., McCreary A.C., Wydra K., Filip M. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. Neuropharmacology 2010, 58(7):1140-1146.
77. Zhang H.Y., Ishigaki T., Tani K., Chen K., Shih J.C., Miyasato K., et al. Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 1997, 41(7):768-773.
78. Zhang J., Shen Y., He G., Li X., Meng J., Guo S., et al. Lack of association between three serotonin genes and suicidal behavior in Chinese psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(2):467-471.